National Account Manager - Rare Disease at AstraZeneca

South Turramurra, New South Wales, Australia -

Full Time

Start Date

Immediate

Expiry Date

24 Mar, 26

Salary

0.0

Posted On

24 Dec, 25

Experience

5 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Account Management, Strategic Planning, KOL Development, Stakeholder Influence, Data Analysis, Promotion, Education, Collaboration, Operational Excellence, Budget Management, CRM Management, Healthcare Provider Engagement, Program Execution, Patient Advocacy, Market Insights, Cross-Functional Coordination, Rare Disease Knowledge

Industry

Pharmaceutical Manufacturing

Description

Do you have experience in speciality/rare disease areas, and a passion for helping patients get the right care earlier? Are you a strategic, scientifically credible account manager who connects stakeholders, turns ideas into pragmatic programs, and advocates for patients in complex care pathways? If so, Alexion may be the right fit for you. This new Sydney or Melbourne based permanent opportunity at Alexion offers the chance to directly influence patient access and clinical practice in paediatric oncology. Significant national activation and clear account plans are in place—you will scale proven models and help elevate care nationally. With a strong pipeline in rare disease, this role offers scope to grow as indications expand and as the team evolves with future products. About AstraZeneca & Alexion Rare Disease: AstraZeneca is a global, science-led biopharmaceutical company transforming treatment across Oncology, CVRM, Respiratory & Immunology and Rare Disease. Alexion, AstraZeneca Rare Disease is dedicated to advancing care for people living with rare diseases. We work alongside clinicians to support appropriate access and redefine what is possible for patients and their families. What you’ll do: As the National Account Manager for Neurofibromatosis Type 1 (NF1), you’ll report to the Franchise Head and drive national account strategy — building KOL advocacy, promoting to healthcare providers, and executing strategic, cross-functional account plans with an omnichannel, partnership-led approach. Operating across expert centres and referral networks, you’ll translate opportunities and field insights into scalable programs that streamline access and elevate care for patients in need, while contributing to strategy within the close-knit, multidisciplinary brand team. Key responsibilities include: Deliver national objectives: Achieve targets through focused execution across priority accounts. Lead strategic account planning: Develop and implement cross-functional plans tailored to small patient populations. Expand advocacy and networks: Identify and develop KOLs; build long-term relationships with expert centres, referring hospitals, and HCPs. Translate insights into action: Analyze indication and market data to set priorities and drive concrete initiatives. Execute compliant promotion and education: Run local programs; brief speakers; engage across physical, virtual, and digital channels. Drive partnership projects: Initiate and manage collaborations with internal/external stakeholders to improve care pathways. Maintain operational excellence: Manage CRM, documentation, budget allocation, and governance/SOP adherence. Represent the brand externally: Attend conferences to deepen therapy knowledge, gather insights, and strengthen HCP relationships; travel nationally as required. Essential for the role: Minimum 5 years Biotechnology/Pharmaceutical Key Account Management experience with proven results in hospital/specialty care. Strong scientific literacy; able to translate complex neurology/oncology data. Demonstrated KOL development and multidisciplinary stakeholder influence across paediatric centres. Developing focused account plans, prioritisation and omnichannel execution; resilient, proactive, collaborative. Operational excellence (CRM, budgeting, documentation, governance) with familiarity with Medicines Australia Code of Conduct. BS degree in a scientific field or relevant industry experience; current, valid driver’s license. Desirable Skills/Experience: Experience in paediatric oncology or paediatric neurology (rare disease); infused/injected product experience highly regarded. Experience with hospital pharmacists, infusion clinics, nurses and MDT coordination. Exposure to launch or competitive environments and applying field insights to develop cross-functional plans. Why Join Alexion, AstraZeneca Rare Disease? At Alexion, we are committed to making a difference through our bold mission: transforming the lives of people living with rare diseases. Recognized as a Great Place to Work, our team welcomes talented, diverse individuals who thrive in a collaborative environment. Here, your voice is heard, your expertise is valued, and your work truly changes lives. So, what’s next? If you are ready to bring new ideas and fresh thinking to our team, we encourage you to apply. We look forward to connecting with candidates who share our commitment to advancing rare disease medicine. Due to our annual Christmas shutdown and with the recruitment team on leave from Monday, 21 December to Sunday, 4 January, applications will be reviewed when the team returns from 5th January 2026. We appreciate your patience and wish you a safe and enjoyable festive season. Where can I find out more? Follow AstraZeneca on LinkedIn https://www.linkedin.com/company/1603/ Visit our website: https://careers.alexion.com/ AstraZeneca in Australia has been formally recognised as an Employer of Choice for Gender Equality by the Workplace Gender Equality Agency (WGEA) and as a Gold Tier Employer within the Australian Workplace Equality Index (AWEI). Visit our ANZ Careers Page - www.astrazeneca.com.au/careers.html & https://careers.alexion.com/ to learn more about our commitment to fostering a flexible, diverse, and inclusive environment. We recognise that any recruitment process may present challenges, if there is anything we can do to make our recruitment process more accessible for you, please let us know via this Form. Date Posted 24-Dec-2025 Closing Date 18-Jan-2026 Alexion is proud to be an Equal Employment Opportunity and Affirmative Action employer. We are committed to fostering a culture of belonging where every single person can belong because of their uniqueness. The Company will not make decisions about employment, training, compensation, promotion, and other terms and conditions of employment based on race, color, religion, creed or lack thereof, sex, sexual orientation, age, ancestry, national origin, ethnicity, citizenship status, marital status, pregnancy, (including childbirth, breastfeeding, or related medical conditions), parental status (including adoption or surrogacy), military status, protected veteran status, disability, medical condition, gender identity or expression, genetic information, mental illness or other characteristics protected by law. Alexion provides reasonable accommodations to meet the needs of candidates and employees. To begin an interactive dialogue with Alexion regarding an accommodation, please contact accommodations@Alexion.com. Alexion participates in E-Verify. For over three decades, patients and their caregivers have been at the center of everything we do. Every day, we are inspired to follow the science and think differently to create better outcomes for them and their families. Our mission is driven by understanding who they are as unique individuals, not solely defined by their diseases. We’re a leading rare disease company with a diversified projects. Our pioneering legacy in rare diseases is rooted in being the first to translate the complex biology of the complement system into transformative medicines over the past three decades. Today, we continue to push the boundaries of science and deepen our understanding of rare diseases with patient-centricity at the core. This knowledge allows us to innovate and evolve into new areas where needs are unmet and provide an opportunity to help people fully live their best lives.

Responsibilities

As the National Account Manager for Neurofibromatosis Type 1 (NF1), you will drive national account strategy, build KOL advocacy, and execute strategic account plans. You will translate insights into scalable programs that improve patient access and care pathways.